Semaphorins in the development, homeostasis and disease of hormone systems

Seminars in Cell and Developmental Biology

Volumn 24, Issue 3, 2013, Pages 190-198

  Giacobini, Paolo ^a,b   Prevot, Vincent ^a,b  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b UNIV LILLE   (France)

Author keywords

Cell migration; Development; Gonadotropin releasing hormone; Hormone; Neuronal plasticity; Reproduction

Indexed keywords

BETA1 INTEGRIN; GONADORELIN; GONADORELIN RECEPTOR; NEUROPILIN 1; PLEXIN; PLEXIN B1; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 3F; SEMAPHORIN 4D; SEMAPHORIN 7A; UNCLASSIFIED DRUG;

CELL MIGRATION; GENE MUTATION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER; NEUROENDOCRINE SYSTEM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84875581222     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.11.005     Document Type: Review

References (108)

1. Kruger R.P., Aurandt J., Guan K.L. Semaphorins command cells to move. Nature Reviews Molecular Cell Biology 2005, 6:789-800.
2. Casazza A., Fazzari P., Tamagnone L. Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms. Advances in Experimental Medicine and Biology 2007, 600:90-108.
3. Tran T.S., Kolodkin A.L., Bharadwaj R. Semaphorin regulation of cellular morphology. Annual Review of Cell and Developmental Biology 2007, 23:263-292.
4. Pasterkamp R.J., Giger R.J. Semaphorin function in neural plasticity and disease. Current Opinion in Neurobiology 2009, 19:263-274.
5. Perala N., Sariola H., Immonen T. More than nervous: the emerging roles of plexins. Differentiation 2012, 83:77-91.
6. Neufeld G., Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nature Reviews Cancer 2008, 8:632-645.
7. Zhou Y., Gunput R.A., Pasterkamp R.J. Semaphorin signaling: progress made and promises ahead. Trends in Biochemical Sciences 2008, 33:161-170.
8. Capparuccia L., Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin. Journal of Cell Science 2009, 122:1723-1736.
9. Ch'ng E.S., Kumanogoh A. Roles of Sema4D and Plexin-B1 in tumor progression. Molecular Cancer 2010, 9:251.
10. Ojeda S.R., Skinner M.K. Physiology of the gonadotropin-releasing hormone neuronal network. Physiology of reproduction 2006, 2061-2126. Elsevier, New York. 3rd ed. E. Knobil, J.D. Neill (Eds.).
11. Wray S. From nose to brain: development of gonadotrophin-releasing hormone-1 neurones. Journal of Neuroendocrinology 2010, 22:743-753.
12. Schwanzel-Fukuda M., Pfaff D.W. Origin of luteinizing hormone-releasing hormone neurons. Nature 1989, 338:161-164.
13. Wray S., Grant P., Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:8132-8136.
14. Gonzalez-Martinez D., Hu Y., Bouloux P.M. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Frontiers in Neuroendocrinology 2004, 25:108-130.
15. Wierman M.E., Kiseljak-Vassiliades K., Tobet S. Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Frontiers in Neuroendocrinology 2011, 32:43-52.
16. Marin O., Rubenstein J.L. Cell migration in the forebrain. Annual Review of Neuroscience 2003, 26:441-483.
17. Wray S. Development of gonadotropin-releasing hormone-1 neurons. Frontiers in Neuroendocrinology 2002, 23:292-316.
18. Schwarting G.A., Wierman M.E., Tobet S.A. Gonadotropin-releasing hormone neuronal migration. Seminars in Reproductive Medicine 2007, 25:305-312.
19. Giacobini P., Messina A., Morello F., Ferraris N., Corso S., Penachioni J., et al. Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex. Journal of Cell Biology 2008, 183:555-566.
20. Giger R.J., Wolfer D.P., De Wit G.M., Verhaagen J. Anatomy of rat semaphorin III/collapsin-1 mRNA expression and relationship to developing nerve tracts during neuroembryogenesis. Journal of Comparative Neurology 1996, 375:378-392.
21. Giger R.J., Cloutier J.F., Sahay A., Prinjha R.K., Levengood D.V., Moore S.E., et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 2000, 25:29-41.
22. Cloutier J.F., Giger R.J., Koentges G., Dulac C., Kolodkin A.L., Ginty D.D. Neuropilin-2 mediates axonal fasciculation, zonal segregation, but not axonal convergence, of primary accessory olfactory neurons. Neuron 2002, 33:877-892.
23. Schwarting G.A., Kostek C., Ahmad N., Dibble C., Pays L., Puschel A.W. Semaphorin 3A is required for guidance of olfactory axons in mice. Journal of Neuroscience 2000, 20:7691-7697.
24. Messina A., Ferraris N., Wray S., Cagnoni G., Donohue D.E., Casoni F., et al. Dysregulation of semaphorin7A/beta1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Human Molecular Genetics 2011, 20:4759-4774.
25. Pasterkamp R.J., Kolk S.M., Hellemons A.J., Kolodkin A.L. Expression patterns of semaphorin7A and plexinC1 during rat neural development suggest roles in axon guidance and neuronal migration. BMC Developmental Biology 2007, 7:98.
26. de Castro F., Hu L., Drabkin H., Sotelo C., Chedotal A. Chemoattraction and chemorepulsion of olfactory bulb axons by different secreted semaphorins. Journal of Neuroscience 1999, 19:4428-4436.
27. Ebert A.M., Lamont R.E., Childs S.J., McFarlane S. Neuronal expression of class 6 semaphorins in zebrafish. Gene Expression Patterns 2012, 10.1016/j.gep.2012.01.07.
28. Elhabazi A., Delaire S., Bensussan A., Boumsell L., Bismuth G. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. Journal of Immunology 2001, 166:4341-4347.
29. Wang X., Kumanogoh A., Watanabe C., Shi W., Yoshida K., Kikutani H. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 2001, 97:3498-3504.
30. Swiercz J.M., Kuner R., Behrens J., Offermanns S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 2002, 35:51-63.
31. Giordano S., Corso S., Conrotto P., Artigiani S., Gilestro G., Barberis D., et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nature Cell Biology 2002, 4:720-724.
32. Conrotto P., Corso S., Gamberini S., Comoglio P.M., Giordano S. Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 2004, 23:5131-5137.
33. Conrotto P., Valdembri D., Corso S., Serini G., Tamagnone L., Comoglio P.M., et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005, 105:4321-4329.
34. Comeau M.R., Johnson R., DuBose R.F., Petersen M., Gearing P., VandenBos T., et al. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 1998, 8:473-482.
35. Lange C., Liehr T., Goen M., Gebhart E., Fleckenstein B., Ensser A. New eukaryotic semaphorins with close homology to semaphorins of DNA viruses. Genomics 1998, 51:340-350.
36. Xu X., Ng S., Wu Z.L., Nguyen D., Homburger S., Seidel-Dugan C., et al. Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins. Journal of Biological Chemistry 1998, 273:22428-22434.
37. Suzuki K., Okuno T., Yamamoto M., Pasterkamp R.J., Takegahara N., Takamatsu H., et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007, 446:680-684.
38. Lazova R., Gould Rothberg B.E., Rimm D., Scott G. The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis. American Journal of Dermatopathology 2009, 31:177-181.
39. Scott G.A., McClelland L.A., Fricke A.F. Semaphorin 7a promotes spreading and dendricity in human melanocytes through beta1-integrins. Journal of Investigative Dermatology 2008, 128:151-161.
40. Scott G.A., McClelland L.A., Fricke A.F., Fender A. Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. Journal of Investigative Dermatology 2009, 129:954-963.
41. Ohsawa S., Hamada S., Asou H., Kuida K., Uchiyama Y., Yoshida H., et al. Caspase-9 activation revealed by semaphorin 7A cleavage is independent of apoptosis in the aged olfactory bulb. Journal of Neuroscience 2009, 29:11385-11392.
42. Ohsawa S., Hamada S., Kuida K., Yoshida H., Igaki T., Miura M. Maturation of the olfactory sensory neurons by Apaf-1/caspase-9-mediated caspase activity. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13366-13371.
43. Pasterkamp R.J., Peschon J.J., Spriggs M.K., Kolodkin A.L. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003, 424:398-405.
44. Fukunishi A., Maruyama T., Zhao H., Tiwari M., Kang S., Kumanogoh A., et al. The action of Semaphorin7A on thalamocortical axon branching. Journal of Neurochemistry 2011, 118:1008-1015.
45. Parkash J., Cimino I., Ferraris N., Casoni F., Wray S., Cappy H., et al. Suppression of β1-integrin in Gonadotropin-Releasing Hormone (GnRH) cells disrupts migration and axonal extension resulting in severe reproductive alterations. Journal of Neuroscience 2012, 32:16992-17002.
46. Yu H.H., Houart C., Moens C.B. Cloning and embryonic expression of zebrafish neuropilin genes. Gene Expression Patterns 2004, 4:371-378.
47. Murakami Y., Suto F., Shimizu M., Shinoda T., Kameyama T., Fujisawa H. Differential expression of plexin-A subfamily members in the mouse nervous system. Developmental Dynamics 2001, 220:246-258.
48. Cariboni A., Hickok J., Rakic S., Andrews W., Maggi R., Tischkau S., et al. Neuropilins and their ligands are important in the migration of gonadotropin-releasing hormone neurons. Journal of Neuroscience 2007, 27:2387-2395.
49. Walz A., Rodriguez I., Mombaerts P. Aberrant sensory innervation of the olfactory bulb in neuropilin-2 mutant mice. Journal of Neuroscience 2002, 22:4025-4035.
50. Imai T., Yamazaki T., Kobayakawa R., Kobayakawa K., Abe T., Suzuki M., et al. Pre-target axon sorting establishes the neural map topography. Science 2009, 325:585-590.
51. Pasterkamp R.J., De Winter F., Holtmaat A.J., Verhaagen J. Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. Journal of Neuroscience 1998, 18:9962-9976.
52. Cariboni A., Davidson K., Rakic S., Maggi R., Parnavelas J.G., Ruhrberg C. Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism. Human Molecular Genetics 2011, 20:336-344.
53. Cariboni A., Davidson K., Dozio E., Memi F., Schwarz Q., Stossi F., et al. VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels. Development 2011, 138:3723-3733.
54. Hanchate N.K., Giacobini P., Lhuillier P., Parkash J., Espy C., Fouveaut C., et al. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with kallmann syndrome. PLoS Genetics 2012, 8:e1002896.
55. Schwanzel-Fukuda M., Bick D., Pfaff D.W. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Research. Molecular Brain Research 1989, 6:311-326.
56. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92:735-745.
57. Gluzman-Poltorak Z., Cohen T., Herzog Y., Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. Journal of Biological Chemistry 2000, 275:29922.
58. Karpanen T., Heckman C.A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB Journal 2006, 20:1462-1472.
59. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
60. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
61. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
62. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
63. Fantin A., Maden C.H., Ruhrberg C. Neuropilin ligands in vascular and neuronal patterning. Biochemical Society Transactions 2009, 37:1228-1232.
64. Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B., et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. Journal of Biological Chemistry 2002, 277:11410-11415.
65. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genetics 2001, 28:131-138.
66. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. Journal of Neuroscience 1999, 19:5731-5740.
67. Gu C., Rodriguez E.R., Reimert D.V., Shu T., Fritzsch B., Richards L.J., et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Developmental Cell 2003, 5:45-57.
68. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. New England Journal of Medicine 1997, 337:1597-1602.
69. Mitchell A.L., Dwyer A., Pitteloud N., Quinton R. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends in Endocrinology and Metabolism 2011, 22:249-258.
70. Balasubramanian R., Crowley W.F. Isolated GnRH deficiency: a disease model serving as a unique prism into the systems biology of the GnRH neuronal network. Molecular and Cellular Endocrinology 2011, 346:4-12.
71. Dode C., Hardelin J.P. Kallmann syndrome. European Journal of Human Genetics 2009, 17:139-146.
72. Sykiotis G.P., Plummer L., Hughes V.A., Au M., Durrani S., Nayak-Young S., et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15140-15144.
73. Young J., Metay C., Bouligand J., Tou B., Francou B., Maione L., et al. SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. Human Reproduction 2012, 27:1460-1465.
74. Lalani S.R., Safiullah A.M., Molinari L.M., Fernbach S.D., Martin D.M., Belmont J.W. SEMA3E mutation in a patient with CHARGE syndrome. Journal of Medical Genetics 2004, 41:e94.
75. Kim H.G., Layman L.C. The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Molecular and Cellular Endocrinology 2011, 346:74-83.
76. Kim H.G., Kurth I., Lan F., Meliciani I., Wenzel W., Eom S.H., et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. American Journal of Human Genetics 2008, 83:511-519.
77. Carmeliet P., Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436:193-200.
78. Larrivee B., Freitas C., Suchting S., Brunet I., Eichmann A. Guidance of vascular development: lessons from the nervous system. Circulation Research 2009, 104:428-441.
79. Makita T., Sucov H.M., Gariepy C.E., Yanagisawa M., Ginty D.D. Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons. Nature 2008, 452:759-763.
80. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature Reviews Neuroscience 2004, 5:347-360.
81. Serini G., Valdembri D., Zanivan S., Morterra G., Burkhardt C., Caccavari F., et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003, 424:391-397.
82. Prevot V., Hanchate N.K., Bellefontaine N., Sharif A., Parkash J., Estrella C., et al. Function-related structural plasticity of the GnRH system: a role for neuronal-glial-endothelial interactions. Frontiers in Neuroendocrinology 2010, 31:241-258.
83. Page R. The anatomy of the hypothalamo-hypophysial complex. Physiology of reproduction 1994, 1527-1619. Raven Press, New York. E. Knobil, J.D. Neill (Eds.).
84. Prevot V., Bellefontaine N., Baroncini M., Sharif A., Hanchate N.K., Parkash J., et al. Gonadotrophin-releasing hormone nerve terminals, tanycytes and neurohaemal junction remodelling in the adult median eminence: functional consequences for reproduction and dynamic role of vascular endothelial cells. Journal of Neuroendocrinology 2010, 22:639-649.
85. Bellefontaine N., Hanchate N.K., Parkash J., Campagne C., de Seranno S., Clasadonte J., et al. Nitric oxide as key mediator of neuron-to-neuron and endothelia-to-glia communication involved in the neuroendocrine control of reproduction. Neuroendocrinology 2011, 93:74-89.
86. Campagne C., Bouret S.G., Leroy D., Beauvillain J.-C., Prevot V. Semaphorin3A may be a chemotropic factor used by endothelial cells of the median eminence to regulate GnRH axon plasticity during the rat estrous cycle. Society for Neuroscience - Abstracts 2008, 618.3.
87. Parkash J., Loyens A., Gallet S., Balland E., Pralong F., Pasterkamp R.J., et al. Semaphorin 7A expression in tanycytes is regulated by sex-steroid hormones and controls gonadotropin-releasing hormone-1 (GnRH-1) cell plasticity. Society for Neuroscience - Abstracts 2011, 500.09/VV29.
88. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annual Review of Neuroscience 1983, 6:269-324.
89. Karim M.A., Sloper J.C. Histogenesis of the supraoptic and paraventricular neurosecretory cells of the mouse hypothalamus. Journal of Anatomy 1980, 130:341-347.
90. Okamura H., Fukui K., Koyama E., Tsutou H.L., Tsutou T., Terubayashi H., et al. Time of vasopressin neuron origin in the mouse hypothalamus: examination by combined technique of immunocytochemistry and [3H]thymidine autoradiography. Brain Research 1983, 285:223-226.
91. Jing X., Ratty A.K., Murphy D. Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus. Neuroscience Research 1998, 30:343-349.
92. Xu C., Fan C.M. Expression of robo/slit and semaphorin/plexin/neuropilin family members in the developing hypothalamic paraventricular and supraoptic nuclei. Gene Expression Patterns 2008, 8:502-507.
93. Xu C., Fan C.M. Allocation of paraventricular and supraoptic neurons requires Sim1 function: a role for a Sim1 downstream gene PlexinC1. Molecular Endocrinology 2007, 21:1234-1245.
94. Armstrong W.E. Hypothalamic supraoptic and paraventricular nuclei. The rat nervous system 1995, 377-390. Academic Press, San Diego. 2nd ed. G. Paxinos (Ed.).
95. Nicks K.M., Fowler T.W., Gaddy D. Reproductive hormones and bone. Current Osteoporosis Reports 2010, 8:60-67.
96. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002, 359:1841-1850.
97. Sutton A.L., Zhang X., Dowd D.R., Kharode Y.P., Komm B.S., Macdonald P.N. Semaphorin 3B is a 1,25-dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice. Molecular Endocrinology 2008, 22:1370-1381.
98. Delorme G., Saltel F., Bonnelye E., Jurdic P., Machuca-Gayet I. Expression and function of semaphorin 7A in bone cells. Biologie Cellulaire 2005, 97:589-597.
99. Koh J.M., Oh B., Lee J.Y., Lee J.K., Kimm K., Kim G.S., et al. Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women. Journal of Human Genetics 2006, 51:112-117.
100. Huang Z., Shimazu K., Woo N.H., Zang K., Muller U., Lu B., et al. Distinct roles of the beta 1-class integrins at the developing and the mature hippocampal excitatory synapse. Journal of Neuroscience 2006, 26:11208-11219.
101. Takegahara N., Takamatsu H., Toyofuku T., Tsujimura T., Okuno T., Yukawa K., et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nature Cell Biology 2006, 8:615-622.
102. Negishi-Koga T., Shinohara M., Komatsu N., Bito H., Kodama T., Friedel R.H., et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nature Medicine 2011, 17:1473-1480.
103. Tasaka G., Negishi M., Oinuma I. Semaphorin 4D/Plexin-B1-mediated M-Ras GAP activity regulates actin-based dendrite remodeling through Lamellipodin. Journal of Neuroscience 2012, 32:8293-8305.
104. Saito Y., Oinuma I., Fujimoto S., Negishi M. Plexin-B1 is a GTPase activating protein for M-Ras, remodelling dendrite morphology. EMBO Reports 2009, 10:614-621.
105. Regev A., Goldman S., Shalev E. Semaphorin-4D (Sema-4D), the Plexin-B1 ligand, is involved in mouse ovary follicular development. Reproductive Biology and Endocrinology 2007, 5:12.
106. Dacquin R., Domenget C., Kumanogoh A., Kikutani H., Jurdic P., Machuca-Gayet I. Control of bone resorption by semaphorin 4D is dependent on ovarian function. PLoS ONE 2011, 6:e26627.
107. Prevot V. Glial-neuronal-endothelial interactions are involved in the control of GnRH secretion. Journal of Neuroendocrinology 2002, 14:247-255.
108. Prevot V., Croix D., Bouret S., Dutoit S., Tramu G., Stefano G.B., et al. Definitive evidence for the existence of morphological plasticity in the external zone of the median eminence during the rat estrous cycle: implication of neuro-glio-endothelial interactions in gonadotropin-releasing hormone release. Neuroscience 1999, 94:809-819.